Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels

International Journal of Cardiology

Volumn 103, Issue 2, 2005, Pages 182-186

  Mayer, Björn ^a   Holmer, Stephan R ^b   Hengstenberg, Christian ^b   Lieb, Wolfgang ^a   Pfeifer, Michael ^b   Schunkert, Heribert ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Beta blockers; Chronic heart failure; IL 6

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CYTOKINE; DIGOXIN; FUROSEMIDE; INTERLEUKIN 6; METOPROLOL SUCCINATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; DOSE CALCULATION; ERGOMETRY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SPIROMETER; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CYTOKINES; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 23244437171     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.08.053     Document Type: Article

References (34)

1. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N. Engl. J. Med. 323 4 1990 236 241
2. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD) J. Am. Coll. Cardiol. 27 5 1996 1201 1206
3. P. Aukrust, T. Ueland, E. Lien, K. Bendtzen, F. Muller, and A.K. Andreassen Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am. J. Cardiol. 83 3 1999 376 382
4. A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, and D.L. Mann Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) Circulation 103 16 2001 2055 2059
5. S. Kapadia, J. Lee, G. Torre-Amione, H.H. Birdsall, T.S. Ma, and D.L. Mann Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration J. Clin. Invest. 96 2 1995 1042 1052
6. E.J. Birks, N. Latif, V. Owen, C. Bowles, L.E. Felkin, and A.J. Mullen Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices Circulation 104 12 Suppl. 1 2001 I223 I240
7. W.S. Bradham, B. Bozkurt, H. Gunasinghe, D. Mann, and F.G. Spinale Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective Cardiovasc. Res. 53 4 2002 822 830
8. D.R. Murray, S.D. Prabhu, and B. Chandrasekar Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression Circulation 101 20 2000 2338 2341
9. L. Gullestad, T. Ueland, A. Brunsvig, J. Kjekshus, S. Simonsen, and S.S. Frolan Effect of metoprolol on cytokine levels in chronic heart failure-a substudy in the metoprolol controlled release randomised intervention trial in heart failure (MERIT-HF) Am. Heart J. 141 3 2001 418 421
10. T. Matsumura, K. Tsushima, E. Ohtaki, K. Misu, T. Tohbaru, and R. Asano Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy J. Cardiol. 39 5 2002 253 257
11. N. Mabuchi, T. Tsutamoto, and M. Kinoshita Therapeutic use of dopamine and beta-blockers modulates plasma interleukin-6 levels in patients with congestive heart failure J. Cardiovasc. Pharmacol. 36 Suppl 2 2000 87 91
12. G.C. Wei, M.G. Sirois, R. Qu, P. Liu, and J.L. Rouleau Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in rat J. Cardiovasc. Pharmacol. 39 6 2002 842 850
13. L. Gullestad, P. Aukrust, T. Ueland, T. Espevik, G. Yee, and R. Vagelos Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure J. Am. Coll. Cardiol. 34 7 1999 2061 2067
14. E.R. Mohler 3rd, L.C. Sorensen, J.K. Ghali, D.D. Schocken, P.W. Willis, and J.A. Bowers Role of cytokines in the mechanism of action of amlodipine: the PRAISE heart failure trial. Prospective randomized amlodipine survival evaluation J. Am. Coll. Cardiol. 30 1 1997 35 41
15. S.D. Prabhu, B. Chandrasekar, D.R. Murray, and G.L. Freeman Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling Circulation 101 17 2000 2103 2109
16. A. Matsumori, H. Igata, K. Ono, A. Iwasaki, T. Miyamoto, and R. Nishio High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity Jpn. Circ. J. 63 12 1999 934 940
17. M. Rauchhaus, W. Doehner, D.P. Francis, C. Davos, M. Kemp, and C. Liebent Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 25 2000 3060 3067
18. T. Tsutamoto, T. Hisanaga, A. Wada, K. Maeda, M. Ohnishi, and D. Fukai Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patient with congestive heart failure J. Am. Coll. Cardiol. 31 2 1998 391 398
19. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF) Lancet 353 9169 1999 2001 2007
20. M.D. Cheitlin, J.S. Alpert, W.F. Armstrong, G.P. Aurigemma, G.A. Beller, and F.Z. Bierman ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography Circulation 95 6 1997 1686 1744
21. R.H. Straub, H.W. Hense, T. Andus, J. Scholmerich, G.A. Riegger, and H. Schunkert Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study J. Clin. Endocrinol. Metab. 85 3 2000 1340 1344
22. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study Circulation 101 4 2000 378 384
23. M. Packer, G.V. Antonopoulos, J.A. Berlin, J. Chittams, M.A. Konstam, and J.E. Udelson Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis Am. Heart J. 141 6 2001 899 907
24. E. Roig, J. Orus, C. Pare, M. Azqueta, X. Filella, and F. Perez-Villa Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy Am. J. Cardiol. 82 5 1998 688 690
25. A.C. Peeters, M.G. Netea, B.J. Kullberg, T. Thien, and J.W. van der Meer The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production Immunology 94 3 1998 376 379
26. A. Nakamura, E.J. Johns, A. Imaizumi, T. Abe, and T. Kohsaka Regulation of tumor necrosis factor and interleukin-6 gene transcription by beta2-adrenoceptor in the rat astrocytes J. Neuroimmunol. 88 1-2 1998 144 153
27. A. Nakamura, E.J. Johns, A. Imaizumi, Y. Yanagawa, and T. Kohsaka Effect of beta(2)-adrenoceptor activation and angiotensin II on tumor necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells Cytokine 11 10 1999 759 765
28. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, and E.M. Gilbert The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N. Engl. J. Med. 334 21 1996 1349 1355
29. P. Dubach, J. Myers, P. Bonetti, T. Schertler, V. Froelicher, and D. Wagner Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging Am. Heart J. 143 4 2002 676 683
30. M. Fujimura, Y. Yasumura, Y. Ishida, S. Nakatani, K. Komamura, and M. Yamagishi Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy J. Card. Fail. 6 1 2000 3 10
31. T. Yoshikawa, S. Handa, T. Anzai, H. Nishimura, A. Baba, and M. Akaishi Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure Am. Heart J. 131 2 1996 329 336
32. J.D. Sackner-Bernstein Use of carvedilol in chronic heart failure: challenges in therapeutic management Prog. Cardiovasc. Dis. 41 1 Suppl. 1 1998 53 58
33. H. Yonemochi, S. Yasunaga, Y. Teshima, N. Takahashi, M. Nakagawa, and M. Ito Rapid electrical stimulation of contraction reduces the density of beta-adrenergic receptors and responsiveness of cultured neonatal rad cardiomyocytes. Possible involvement of microtubule disassembly secondary to mechanical stress Circulation 101 22 2000 2625 2630
34. Y. Nakamura, T. Ryoke, N. Tanaka, T. Ohkusa, and M. Matsuzaki Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamster with advanced heart failure J. Cardiovasc. Pharmacol. 31 2 1998 171 178